Volume 108; Issue 8

Main
Thrombosis and Haemostasis
Volume 108; Issue 8

Thrombosis and Haemostasis

Volume 108; Issue 8

1

Lethal factor VII deficiency due to novel mutations in the F7 promoter: Functional analysis reveals disruption of HNF4 binding site

Giansily-Blaizot, Muriel, Lopez, Estelle, Viart, Victoria, Chafa, Ouerdia, Tapon-Bretaudière, Jacqueline, Claustres, Mireille, Taulan, Magali

Journal:

Thrombosis and Haemostasis

Year:

2012

Language:

english

File:

PDF, 222 KB

english, 2012

2

A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system

Yu, Yuan-Bin, Gau, Jyh-Pyng, Liu, Chun-Yu, Yang, Muh-Hwa, Chiang, Shu-Chiung, Hsu, Hui-Chi, Hong, Ying-Chung, Hsiao, Liang-Tsai, Liu, Jin-Hwang, Chiou, Tzeon-Jye, Chen, Po-Min, Lee, Tzong-Shyuan, Chou

Journal:

Thrombosis and Haemostasis

Year:

2012

Language:

english

File:

PDF, 260 KB

english, 2012

3

Venous thromboembolism: Annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates

Mahan, Charles E., Borrego, Matthew E., Woersching, Alex L., Federici, Robert, Downey, Ross, Tiongson, Jay, Bieniarz, Mark C., Cavanaugh, Brendan J., Spyropoulos, Alex C.

Journal:

Thrombosis and Haemostasis

Year:

2012

Language:

english

File:

PDF, 217 KB

english, 2012

4

The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa

Peraramelli, Sameera, Suylen, Dennis P. L., Rosing, Jan, Hackeng, Tilman M.

Journal:

Thrombosis and Haemostasis

Year:

2012

File:

PDF, 2.69 MB

2012

5

Contra: “Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery”

Douketis, James D.

Journal:

Thrombosis and Haemostasis

Year:

2012

Language:

english

File:

PDF, 58 KB

english, 2012

6

The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa

Peraramelli, Sameera, Suylen, Dennis P. L., Rosing, Jan, Hackeng, Tilman M.

Journal:

Thrombosis and Haemostasis

Year:

2012

Language:

english

File:

PDF, 2.69 MB

english, 2012

7

Anticoagulation in ambulatory cancer patients with no indication for prophylactic or therapeutic anticoagulation

Pishko, Allyson M., Smith, Kenneth J., Ragni, Margaret V.

Journal:

Thrombosis and Haemostasis

Year:

2012

Language:

english

File:

PDF, 265 KB

english, 2012

8

P2Y12 inhibitors in acute coronary syndromes: How do we choose the best drug for our patients?

Kristensen, Steen D., Grove, Erik L., Hvas, Anne-Mette

Journal:

Thrombosis and Haemostasis

Year:

2012

Language:

english

File:

PDF, 62 KB

english, 2012

9

The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease

Jilma-Stohlawetz, Petra, Knöbl, Paul, Gilbert, James C., Jilma, Bernd

Journal:

Thrombosis and Haemostasis

Year:

2012

Language:

english

File:

PDF, 257 KB

english, 2012

10

The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: Roles of white blood cell count and body weight

Morel, Olivier, El Ghannudi, Soraya, Hess, Sebastien, Reydel, Antje, Crimizade, Ulun, Jesel, Laurence, Radulescu, Bogdan, Wiesel, Marie L., Gachet, Christian, Ohlmann, Patrick

Journal:

Thrombosis and Haemostasis

Year:

2012

Language:

english

File:

PDF, 311 KB

english, 2012

11

Platelets selectively enhance lymphocyte adhesion on subendothelial matrix under arterial flow conditions

Spectre, Galia, Zhu, Linjing, Ersoy, Maria, Hjemdahl, Paul, Savion, Naphtali, Varon, David, Li, Nailin

Journal:

Thrombosis and Haemostasis

Year:

2012

Language:

english

File:

PDF, 421 KB

english, 2012